Lawrence A Yannuzzi1. 1. LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear & Throat Hospital, and the Macula Foundation, Inc., New York, NY 10065, USA. maculafoundation@yahoo.com
Abstract
PURPOSE: To review the history of indocyanine green (ICG) angiography and to present a personal perspective on its use in the clinical setting today. DESIGN: Perspective with literature review and opinions based on personal experience. METHODS: To acquire views from international retinal physicians experienced with the technique on uses in their facilities and to compare them to the author's personal standards. RESULTS: The author and contributing retinal physicians had surprisingly similar views for most, but not all, applications for ICG angiography use in the clinical setting. CONCLUSIONS: ICG angiography is recommended for a few highly selective chorioretinal disorders, including certain forms of neovascularization in age-related macular degeneration, other neovascular maculopathies, chronic central serous chorioretinopathy, choroidal hemangiomas, and posterior uveitis.
PURPOSE: To review the history of indocyanine green (ICG) angiography and to present a personal perspective on its use in the clinical setting today. DESIGN: Perspective with literature review and opinions based on personal experience. METHODS: To acquire views from international retinal physicians experienced with the technique on uses in their facilities and to compare them to the author's personal standards. RESULTS: The author and contributing retinal physicians had surprisingly similar views for most, but not all, applications for ICG angiography use in the clinical setting. CONCLUSIONS:ICG angiography is recommended for a few highly selective chorioretinal disorders, including certain forms of neovascularization in age-related macular degeneration, other neovascular maculopathies, chronic central serous chorioretinopathy, choroidal hemangiomas, and posterior uveitis.
Authors: Rupesh Agrawal; Praveen Kumar Balne; Sai Bo Bo Tun; Yeo Sia Wey; Neha Khandelwal; Veluchamy A Barathi Journal: J Vis Exp Date: 2017-07-03 Impact factor: 1.355
Authors: Li Zhang; Kyungmoo Lee; Meindert Niemeijer; Robert F Mullins; Milan Sonka; Michael D Abràmoff Journal: Invest Ophthalmol Vis Sci Date: 2012-11-01 Impact factor: 4.799